These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 8832035)

  • 1. Autologous stem cell transplantation with stem cells preserved in the presence of 4.5 and 2.2% DMSO.
    Lakota J; Fuchsberger P
    Bone Marrow Transplant; 1996 Jul; 18(1):262-3. PubMed ID: 8832035
    [No Abstract]   [Full Text] [Related]  

  • 2. Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation.
    Akkök CA; Liseth K; Nesthus I; Løkeland T; Tefre K; Bruserud O; Abrahamsen JF
    Transfusion; 2008 May; 48(5):877-83. PubMed ID: 18298599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of different DMSO concentrations for cryopreservation of autologous peripheral blood stem cell grafts does not have any major impact on levels of leukocyte- and platelet-derived soluble mediators.
    Akkök CA; Liseth K; Hervig T; Ryningen A; Bruserud Ø; Ersvaer E
    Cytotherapy; 2009; 11(6):749-60. PubMed ID: 19878061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxide.
    Morris C; de Wreede L; Scholten M; Brand R; van Biezen A; Sureda A; Dickmeiss E; Trneny M; Apperley J; Chiusolo P; van Imhoff GW; Lenhoff S; Martinelli G; Hentrich M; Pabst T; Onida F; Quinn M; Kroger N; de Witte T; Ruutu T;
    Transfusion; 2014 Oct; 54(10):2514-22. PubMed ID: 24964911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncontrolled-rate freezing of peripheral blood progenitor cells allows successful engraftment by sparing primitive and committed hematopoietic progenitors.
    Almici C; Ferremi P; Lanfranchi A; Ferrari E; Verardi R; Marini M; Rossi G
    Haematologica; 2003 Dec; 88(12):1390-5. PubMed ID: 14687993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term storage of peripheral blood stem cells frozen and stored with a conventional liquid nitrogen technique compared with cells frozen and stored in a mechanical freezer.
    McCullough J; Haley R; Clay M; Hubel A; Lindgren B; Moroff G
    Transfusion; 2010 Apr; 50(4):808-19. PubMed ID: 19912586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoietic engraftment of dimethyl sulfoxide-depleted autologous peripheral blood progenitor cells.
    Akkök CA; Holte MR; Tangen JM; Ostenstad B; Bruserud O
    Transfusion; 2009 Feb; 49(2):354-61. PubMed ID: 18980622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the cryoprotective solutions based on human albumin vs. autologous plasma: its effect on cell recovery, clonogenic potential of peripheral blood hematopoietic progenitor cells and engraftment after autologous transplantation.
    Smagur A; Mitrus I; Ciomber A; Panczyniak K; Fidyk W; Sadus-Wojciechowska M; Holowiecki J; Giebel S
    Vox Sang; 2015 May; 108(4):417-24. PubMed ID: 25753814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluations of bioantioxidants in cryopreservation of umbilical cord blood using natural cryoprotectants and low concentrations of dimethylsulfoxide.
    Motta JP; Gomes BE; Bouzas LF; Paraguassú-Braga FH; Porto LC
    Cryobiology; 2010 Jun; 60(3):301-7. PubMed ID: 20152822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryopreserving with increased cellular concentrations of peripheral blood progenitor cells: clinical results.
    Villalón L; Odriozola J; Ramos P; Ramos ML; Herrera P; de Oteyza JP
    Haematologica; 2002 Feb; 87(2):ELT06. PubMed ID: 11836183
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparison of different cryopreservation systems for peripheral blood stem cells].
    Huang YZ; Shen JL; Yang PD; Wu NH; Tang XF; Gong LZ; Cen J; Wang LX; Wang N; Zheng PH
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2008 Feb; 24(1):125-8. PubMed ID: 21141576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of different dimethyl sulphoxide concentrations on cell recovery, viability and clonogenic potential of cryopreserved peripheral blood hematopoietic stem and progenitor cells.
    Smagur A; Mitrus I; Giebel S; Sadus-Wojciechowska M; Najda J; Kruzel T; Czerw T; Gliwinska J; Prokop M; Glowala-Kosinska M; Chwieduk A; Holowiecki J
    Vox Sang; 2013 Apr; 104(3):240-7. PubMed ID: 23046417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic cell transplantation using plasma and DMSO without HES, with non-programmed freezing by immersion in a methanol bath: results in 213 cases.
    Hernández-Navarro F; Ojeda E; Arrieta R; Ríos-Rull P; García-Bustos J; Quevedo E; Martín Hernández MP; Jiménez-Yuste V; Rodríguez-Luaces M; López RM; García-Miguel P; Martínez A; Sastre A; Calero F; Gómez-Pastrana F; Martínez B
    Bone Marrow Transplant; 1998 Mar; 21(5):511-7. PubMed ID: 9535044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5% Me2SO is sufficient to preserve stem cells derived from cord blood.
    Richter E; Eichler H; Raske D; Leveringhaus A; Zieger W; Kerowgan M; Goldmann SF
    Bone Marrow Transplant; 1998 Jul; 22 Suppl 1():S16. PubMed ID: 9715875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Processing of hematopoietic stem cells from peripheral blood before cryopreservation: use of a closed automated system.
    Zinno F; Landi F; Scerpa MC; Aureli V; Lanti A; Ceccarelli S; Caniglia M; Miele MJ; Daniele N; Landolfo A; Cometa AM; Locatelli F; Isacchi G
    Transfusion; 2011 Dec; 51(12):2656-63. PubMed ID: 21599671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryopreservation of peripheral blood stem cell: the influence of cell concentration on cellular and hematopoietic recovery.
    Alencar S; Garnica M; Luiz RR; Nogueira CM; Borojevic R; Maiolino A; Dutra HS
    Transfusion; 2010 Nov; 50(11):2402-12. PubMed ID: 20573073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of cryopreservation condition for hematopoietic stem cells from umbilical cord blood.
    Son JH; Heo YJ; Park MY; Kim HH; Lee KS
    Cryobiology; 2010 Jun; 60(3):287-92. PubMed ID: 20138169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical toxicity of cryopreserved circulating progenitor cells infusion.
    Zambelli A; Poggi G; Da Prada G; Pedrazzoli P; Cuomo A; Miotti D; Perotti C; Preti P; Robustelli della Cuna G
    Anticancer Res; 1998; 18(6B):4705-8. PubMed ID: 9891544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation in dimethyl sulfoxide use in stem cell transplantation: a survey of EBMT centres.
    Windrum P; Morris TC; Drake MB; Niederwieser D; Ruutu T;
    Bone Marrow Transplant; 2005 Oct; 36(7):601-3. PubMed ID: 16044141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective cryopreservation of cytokine-mobilized autologous peripheral blood stem cells using non-controlled rate freezing.
    Warkentin PI; Jackson JD; Letheby B; Kessinger A
    Prog Clin Biol Res; 1994; 389():643-7. PubMed ID: 7700931
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.